2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Agarwal Rashmi | — | 8,554,945 | Apr 13, 2023 |
| Agarwal Vipin | — | 8,554,945 | Apr 13, 2023 |
| Gupta Tarun K. | — | 8,550,396 | Apr 13, 2023 |
| Gupta Indu R. | — | 8,550,396 | Apr 13, 2023 |
| Balasubramanian Suganthi | — | 8,547,750 | Apr 14, 2023 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 9, 2026 | Jan 12, 2026 | Laumas Sandeep | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 9, 2026 | Jan 12, 2026 | Patni Rajiv | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 9, 2026 | Jan 12, 2026 | MUELLER PETER | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 9, 2026 | Jan 12, 2026 | Votruba Michal | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 9, 2026 | Jan 12, 2026 | MILLER MICHAEL PATRICK | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 9, 2026 | Jan 12, 2026 | Bray June | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 9, 2026 | Jan 12, 2026 | MACK DAVID J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 1, 2026 | Jan 5, 2026 | Yocca Frank | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 1, 2026 | Jan 5, 2026 | Steinhart Richard I | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 1, 2026 | Jan 5, 2026 | Mehta Vimal | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 1, 2026 | Jan 5, 2026 | Rodriguez Javier | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 14, 2025 | Dec 15, 2025 | Mehta Vimal | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 14, 2025 | Dec 15, 2025 | Steinhart Richard I | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 14, 2025 | Dec 15, 2025 | Rodriguez Javier | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 14, 2025 | Dec 15, 2025 | Yocca Frank | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 31, 2025 | Nov 3, 2025 | MACK DAVID J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 30, 2025 | Oct 1, 2025 | MACK DAVID J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 14, 2025 | Sep 16, 2025 | Mehta Vimal | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 14, 2025 | Sep 16, 2025 | Steinhart Richard I | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 14, 2025 | Sep 16, 2025 | Rodriguez Javier | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 14, 2025 | Sep 16, 2025 | Yocca Frank | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 31, 2025 | Sep 2, 2025 | MACK DAVID J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 1, 2025 | Aug 5, 2025 | Steinhart Richard I | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 1, 2025 | Aug 5, 2025 | Rodriguez Javier | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 1, 2025 | Aug 5, 2025 | Yocca Frank | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 1, 2025 | Aug 5, 2025 | Mehta Vimal | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 31, 2025 | Jul 31, 2025 | MACK DAVID J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 22, 2025 | Jul 22, 2025 | Mehta Vimal | CEO | Neutral | 82.5 | +15,625 | 3.22% | ✗ | - |
| Jul 22, 2025 | Jul 22, 2025 | Yocca Frank | Chief Scientific Officer | Neutral | 90.0 | +4,375 | 225.40% | ✗ | - |
| Jul 22, 2025 | Jul 22, 2025 | Steinhart Richard I | CFO | Neutral | 90.0 | +4,375 | 303.61% | ✗ | - |
| Jul 22, 2025 | Jul 22, 2025 | Rodriguez Javier | Officer | Neutral | 90.0 | +4,375 | 263.71% | ✗ | - |
| Jun 30, 2025 | Jun 30, 2025 | MACK DAVID J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 14, 2025 | Jun 16, 2025 | Steinhart Richard I | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 14, 2025 | Jun 16, 2025 | Yocca Frank | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 14, 2025 | Jun 16, 2025 | Mehta Vimal | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 14, 2025 | Jun 16, 2025 | Rodriguez Javier | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 31, 2025 | Jun 2, 2025 | MACK DAVID J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 30, 2025 | May 1, 2025 | MACK DAVID J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 22, 2024 | Apr 1, 2025 | O'Neill Vincent | Other | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 22, 2024 | Apr 1, 2025 | Mehta Vimal | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 22, 2024 | Apr 1, 2025 | Steinhart Richard I | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 22, 2024 | Apr 1, 2025 | Wiley Matthew T. | Other | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 22, 2024 | Apr 1, 2025 | Rodriguez Javier | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 22, 2024 | Apr 1, 2025 | Yocca Frank | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 31, 2025 | Apr 1, 2025 | MACK DAVID J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 14, 2025 | Mar 17, 2025 | Steinhart Richard I | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 14, 2025 | Mar 17, 2025 | Rodriguez Javier | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 14, 2025 | Mar 17, 2025 | Yocca Frank | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 14, 2025 | Mar 17, 2025 | Mehta Vimal | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 28, 2025 | Mar 4, 2025 | MACK DAVID J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 31, 2025 | Feb 4, 2025 | MACK DAVID J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 15, 2025 | Jan 16, 2025 | Patni Rajiv | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 16, 2025 | Patni Rajiv | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 7, 2025 | Jan 10, 2025 | Mehta Vimal | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 7, 2025 | Jan 10, 2025 | Yocca Frank | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 7, 2025 | Jan 10, 2025 | Steinhart Richard I | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 31, 2024 | Jan 3, 2025 | MACK DAVID J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 14, 2024 | Dec 17, 2024 | O'Neill Vincent | Officer | Sell | 52.5 | -165 | -0.82% | ✓ | $58.1 |
| Dec 14, 2024 | Dec 17, 2024 | Mehta Vimal | CEO | Sell | 58.8 | -3,117 | -0.04% | ✓ | $1.1K |
| Dec 14, 2024 | Dec 17, 2024 | Steinhart Richard I | CFO | Sell | 50.0 | -577 | -1.35% | ✓ | $207 |
| Dec 14, 2024 | Dec 17, 2024 | Rodriguez Javier | Officer | Sell | 50.0 | -430 | -1.73% | ✓ | $153 |
| Dec 14, 2024 | Dec 17, 2024 | Yocca Frank | Chief Scientific Officer | Sell | 50.0 | -430 | -1.46% | ✓ | $151.8 |
| Nov 30, 2024 | Dec 4, 2024 | MACK DAVID J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 30, 2024 | Dec 3, 2024 | MACK DAVID J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 21, 2024 | Nov 25, 2024 | MACK DAVID J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 25, 2024 | MACK DAVID J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Sep 17, 2024 | Oct 3, 2024 | Wiley Matthew T. | Chief Commercial Officer | Sell | 90.0 | +14,978 | 371.39% | ✓ | $3.4K |
| Sep 17, 2024 | Oct 3, 2024 | Rodriguez Javier | Officer | Sell | 90.0 | +14,387 | 153.33% | ✓ | $3.8K |
| Sep 17, 2024 | Oct 3, 2024 | Yocca Frank | Chief Scientific Officer | Sell | 90.0 | +14,075 | 99.10% | ✓ | $3.9K |
| Sep 17, 2024 | Oct 3, 2024 | Steinhart Richard I | CFO | Sell | 90.0 | +14,075 | 226.87% | ✓ | $3.9K |
| Sep 17, 2024 | Oct 3, 2024 | O'Neill Vincent | Officer | Sell | 90.0 | +15,694 | 401.69% | ✓ | $3.1K |
| Sep 14, 2024 | Sep 17, 2024 | Yocca Frank | Chief Scientific Officer | Sell | 46.3 | -355 | -2.44% | ✓ | $244.7 |
| Sep 14, 2024 | Sep 17, 2024 | Mehta Vimal | CEO | Sell | 58.8 | -1,982 | -0.03% | ✓ | $1.4K |
| Sep 14, 2024 | Sep 17, 2024 | Steinhart Richard I | CFO | Sell | 37.5 | -356 | -5.43% | ✓ | $245.6 |
| Sep 14, 2024 | Sep 17, 2024 | Rodriguez Javier | Officer | Sell | 42.5 | -345 | -3.64% | ✓ | $238.1 |
| Sep 14, 2024 | Sep 17, 2024 | O'Neill Vincent | Officer | Sell | 42.5 | -138 | -3.41% | ✓ | $95.3 |
| Sep 15, 2024 | Sep 17, 2024 | Wiley Matthew T. | Chief Commercial Officer | Sell | 37.5 | -215 | -5.06% | ✓ | $148.5 |
| Jun 15, 2024 | Sep 17, 2024 | Wiley Matthew T. | Chief Commercial Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 14, 2024 | Jun 18, 2024 | Yocca Frank | Chief Scientific Officer | Sell | 46.3 | -372 | -2.69% | ✓ | $476.2 |
| Jun 15, 2024 | Jun 18, 2024 | Wiley Matthew T. | Chief Commercial Officer | Sell | 37.5 | -244 | -6.52% | ✓ | $308.1 |
| Jun 14, 2024 | Jun 18, 2024 | Steinhart Richard I | CFO | Sell | 37.5 | -372 | -6.36% | ✓ | $469.5 |
| Jun 14, 2024 | Jun 18, 2024 | Rodriguez Javier | Officer | Sell | 42.5 | -361 | -4.12% | ✓ | $456 |
| Jun 14, 2024 | Jun 18, 2024 | O'Neill Vincent | Officer | Sell | 42.5 | -155 | -4.21% | ✓ | $199.2 |
| Jun 14, 2024 | Jun 18, 2024 | Mehta Vimal | CEO | Sell | 58.8 | -2,134 | -0.03% | ✓ | $2.7K |
| Jun 18, 2024 | O'Neill Vincent | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 10, 2024 | Jun 11, 2024 | Votruba Michal | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2024 | Jun 11, 2024 | Laumas Sandeep | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2024 | Jun 11, 2024 | MUELLER PETER | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2024 | Jun 11, 2024 | MILLER MICHAEL PATRICK | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2024 | Jun 11, 2024 | Bray June | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 4, 2024 | Jun 6, 2024 | Mehta Vimal | CEO | Sell | 20.0 | -1,427,494 | -15.59% | ✗ | $405.1K |
| Mar 14, 2024 | Apr 8, 2024 | O'Neill Vincent | Officer | Sell | 46.3 | -165 | -2.96% | ✓ | $432.5 |
| Mar 14, 2024 | Apr 8, 2024 | Mehta Vimal | CEO | Sell | 55.0 | -5,268 | -0.06% | ✓ | $13.8K |
| Mar 14, 2024 | Apr 8, 2024 | Steinhart Richard I | CFO | Sell | 25.0 | -1,069 | -18.32% | ✓ | $2.8K |
| Mar 15, 2024 | Apr 8, 2024 | Wiley Matthew T. | CHIEF COMMERCIAL OFFICER | Sell | 15.0 | -1,008 | -25.20% | ✓ | $2.7K |
| Mar 14, 2024 | Apr 8, 2024 | Rodriguez Javier | Officer | Sell | 30.0 | -1,012 | -11.65% | ✓ | $2.7K |
| Mar 14, 2024 | Apr 8, 2024 | Yocca Frank | Chief Scientific Officer | Sell | 33.8 | -1,067 | -7.72% | ✓ | $2.8K |
| Dec 14, 2023 | Dec 18, 2023 | Yocca Frank | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 14, 2023 | Dec 18, 2023 | Mehta Vimal | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 14, 2023 | Dec 18, 2023 | Rodriguez Javier | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |